Bereaved families of children who died of cancer expressed a strong desire for high-quality end-of-life care that balanced comfort with continued treatment efforts, particularly chemotherapy, ...

Giredestrant has a stronger anti-proliferative effect than anastrozole in patients with estrogen receptor-positive, HER2-negative, previously untreated early breast cancer, a new study suggests.

Teclistamab produced “clinically meaningful” responses in patients with heavily pretreated multiple myeloma who had received prior anti-BCMA treatment, according to researchers.

A qualitative exploratory study sought to explore how patients with breast cancer returned to their role as wife after cancer treatment.

Response rates seen in patients with high-risk biochemically recurrent prostate cancer after radical prostatectomy.

In a systematic review, researchers evaluated English-language studies that measured associations between the perceived injustice of pain and physical, functional, and psychosocial outcomes in ...

Researchers sought to determine whether fixed-duration therapy would still be feasible for patients with RRMM who were treated with a bispecific antibody in clinical trials and discontinued.

The CCL17/CCL22-CCR4 axis can be used as a novel biomarker for the prognosis of B-cell acute lymphoblastic leukemia (ALL), according to a new study published in the journal Cytokine. It is already ...

Return to work two years after diagnosis associated with higher cognitive speed performance before and after cancer treatment.

A retrospective study of patients with lymphoma identified risk factors for clinically significant CMV infection in this patient population.

Researchers say the data indicate cancer cases continued to be underdiagnosed in the second year of the pandemic.

Vaccination coverage generally stable for VFC-eligible adolescents during COVID-19 except for decline in those up to date with HPV.